{"id": "1356675395618226181", "text": "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia https://t.co/mfdBIOrS2E", "created_at": "2021-02-02T18:46:34.000Z", "lang": "en", "diputado": {"apellidos": "Pastor Juli\u00e1n", "formacion": "PP", "apellidosNombre": "Pastor Juli\u00e1n, Ana Mar\u00eda", "fchBaja": "", "genero": 2, "fchAlta": "19/11/2019", "idLegislatura": 14, "grupo": "Grupo Parlamentario Popular en el Congreso", "idCircunscripcion": 28, "nombreCircunscripcion": "Madrid", "nombre": "Ana Mar\u00eda", "codParlamentario": 31, "twitter": "https://twitter.com/anapastorjulian", "twitterUserName": "anapastorjulian", "twitterUserId": "307570052"}}